Wearable Cardioverter Defibrillators Market Share

Statistics for the 2023 & 2024 Wearable Cardioverter Defibrillators market share, created by Mordor Intelligence™ Industry Reports. Wearable Cardioverter Defibrillators share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Wearable Cardioverter Defibrillators Industry

The wearable cardioverter defibrillator market is moderately consolidated, with few players globally. In terms of market share, few of the major players currently dominate the market. With the rising patient awareness levels and high prevalence of diseases, many regional players are expected to be part of the wearable cardioverter defibrillator market over the forecast period. Some of the major players in the market are LivaNova PLC, Koninklijke Philips NV, Zoll Medical Corporation, Stryker Corporation, Medtronic PLC, Nihon Kohden Corporation, Kestra Medical Technologies Inc., Boston Scientific Corporation, Element Science and others.

Wearable Cardioverter Defibrillators Market Leaders

  1. Stryker Corporation

  2. Koninklijke Philips N.V.

  3. Element Science, Inc.

  4. Kestra Medical Technologies Inc.

  5. Asahi Kasei Corporation (ZOLL Medical Corporation)

*Disclaimer: Major Players sorted in no particular order

Wearable Cardioverter Defibrillators Market Concentration

Implantable Cardioverter Defibrillator Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)